<DOC>
	<DOCNO>NCT00726440</DOCNO>
	<brief_summary>The `` Capteur Evadiac '' study group , compose French Belgian diabetologists , design 1 year randomize control multicenter study order define best clinical way use continuous glucose monitoring long term improve metabolic control uncontrolled type 1 diabetes patient .</brief_summary>
	<brief_title>Are Continuous Glucose Monitoring Systems Able Improve Long Term Glycaemic Control Type 1 Diabetic Patients ?</brief_title>
	<detailed_description>The primary objective study determine whether patient chronically poor glycaemic control evidence HbA1c &gt; = 8 % twice achieve improve metabolic control use one year CGM together educative program insulin adaptation dos compare conventional self monitoring finger stick educative program insulin adaptation dose alone .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 Diabetes ≥ 12 month ( include Cpeptide negative secondary diabetes ) Children 8 18 year old Adults 18 60 year old Patients treated basalbolus insulin regimen , pump multiple daily injection , analog , least 6 month Performing least 2 finger stick glucose control per day Able motivate use device HbA1c ≥ 8 % twice HPLC method ( DCA 2000 exclude ) Written informed consent obtain prior enrollment study Blindness impair vision screen recognize Allergy sensor Active proliferative retinopathy stabilize laser vitrectomy occurence 6 month prior visit 1 , unstable ( rapidly progress ) retinopathy may require photocoagulation surgical treatment study Treatment systemic corticosteroid medication know influence insulin sensitivity 3 month prioir visit 1 Pregnancy Manifest psychiatric disturbance Presence condition ( medical , include clinically significant abnormal laboratory test , psychological , social geographical ) actuel anticipate investigator feel would compromise patient safety limit his/her successful participation study . Hemoglobinopathy interfers HbA1c measurement</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Real Time Continuous Glucose Monitoring System</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Navigator®</keyword>
</DOC>